Verrica Pharmaceuticals Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -7.13 | -100% |
| P/S |
|
57.52 | 33.77 | 70.34% |
|
|
| P/BV |
|
14.91 | 4.83 | 208.88% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
-4.34 | -22.17 | -80.43% |
|
|
| Ev/S |
|
52.83 | 22.57 | 134.03% |
|
|
| Ev/FCF |
|
-6.95 | 68.76 | -110.11% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1217.53 | 4.97 | -24587.3% | -510 | +138.73% |
| ROE |
|
-338.99 | 9.61 | -3626.91% |
|
|
| ROA |
|
-82.1 | 0.3443 | -23949.67% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-1307.47 | -25.17 | 5094.53% |
|
|
| ROCE |
|
-319.9 | 15.45 | -2170.62% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.6985 | -3.68 | -81% | -0.7219 | -3.24% |
| Nеt Debt/Ebitda |
|
0.3853 | -3.44 | -111.21% |
|
|
| Debt/Ratio |
|
0.534 | 0.1986 | 168.91% |
|
|
| Debt/Equity |
|
11.17 | 1.66 | 572.11% |
|
|
| Debt/Net Income |
|
-0.6504 | 10.32 | -106.3% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-57.3 | -57.64 | -0.5899% | ||
| Growth impulse Ebitda in 5 years |
|
106.63 | -90.94 | -217.25% | ||
| Growth impulse Net Income in 5 years |
|
156.69 | -97.8 | -260.21% | ||
| Growth impulse FCF in 5 years |
|
38.57 | -108.72 | -135.48% | ||
| Growth impulse EPS in 5 years |
|
40.72 | -142.05 | -128.67% |
IP Score
3.35/10
